Should AbbVie Stock Be in Your Portfolio Pre-Q3 Earnings?

AbbVie (ABBV) is set to report third-quarter earnings on Oct. 30, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $14.28 billion and$2.93 per share, respectively.The company’s earnings estimates have declined from $10.87 per share to$10.86 for 2024 in the past 60 days. During the same timeframe, estimates for 2025 have increased from $12.09 to$12.10. Image Source: Zacks Investment ResearchStay up-to-date with all quarterly releases: See Zacks Earnings Calendar.AB ...